annual operating expenses:
$202.10M+$53.17M(+35.70%)Summary
- As of today (September 19, 2025), CLDX annual total operating expenses is $202.10 million, with the most recent change of +$53.17 million (+35.70%) on December 31, 2024.
- During the last 3 years, CLDX annual operating expenses has risen by +$128.30 million (+173.85%).
- CLDX annual operating expenses is now at all-time high.
Performance
CLDX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$63.71M+$1.15M(+1.83%)Summary
- As of today (September 19, 2025), CLDX quarterly total operating expenses is $63.71 million, with the most recent change of +$1.15 million (+1.83%) on June 1, 2025.
- Over the past year, CLDX quarterly operating expenses has increased by +$15.70 million (+32.69%).
- CLDX quarterly operating expenses is now at all-time high.
Performance
CLDX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CLDX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.7% | +32.7% |
| 3 y3 years | +173.8% | +134.7% |
| 5 y5 years | +247.9% | +390.2% |
CLDX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +173.8% | at high | +134.7% |
| 5 y | 5-year | at high | +254.6% | at high | +520.8% |
| alltime | all time | at high | >+9999.0% | at high | +3487.3% |
CLDX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $63.71M(+1.8%) |
| Mar 2025 | - | $62.57M(+11.0%) |
| Dec 2024 | $202.10M(+35.7%) | $56.38M(+3.4%) |
| Sep 2024 | - | $54.53M(+13.6%) |
| Jun 2024 | - | $48.02M(+20.1%) |
| Mar 2024 | - | $39.99M(+3.9%) |
| Dec 2023 | $148.93M(+36.1%) | $38.50M(-8.3%) |
| Sep 2023 | - | $41.99M(+28.3%) |
| Jun 2023 | - | $32.72M(+0.0%) |
| Mar 2023 | - | $32.71M(+13.5%) |
| Dec 2022 | $109.45M(+48.3%) | $28.82M(+5.1%) |
| Sep 2022 | - | $27.43M(+1.1%) |
| Jun 2022 | - | $27.14M(+14.1%) |
| Mar 2022 | - | $23.79M(+18.1%) |
| Dec 2021 | $73.80M(+29.5%) | $20.14M(+4.8%) |
| Sep 2021 | - | $19.23M(+45.8%) |
| Jun 2021 | - | $13.18M(-18.4%) |
| Mar 2021 | - | $16.16M(+57.4%) |
| Dec 2020 | $56.99M(-1.9%) | $10.26M(-25.0%) |
| Sep 2020 | - | $13.68M(+5.3%) |
| Jun 2020 | - | $13.00M(+2.9%) |
| Mar 2020 | - | $12.63M(-0.3%) |
| Dec 2019 | $58.10M(-32.4%) | $12.67M(-9.2%) |
| Sep 2019 | - | $13.96M(+5.2%) |
| Jun 2019 | - | $13.27M(-9.2%) |
| Mar 2019 | - | $14.62M(+6.1%) |
| Dec 2018 | $85.94M(-29.6%) | $13.78M(-6.3%) |
| Sep 2018 | - | $14.70M(-39.5%) |
| Jun 2018 | - | $24.31M(+2.9%) |
| Mar 2018 | - | $23.62M(-9.6%) |
| Dec 2017 | $122.07M(-12.6%) | $26.13M(+10.4%) |
| Sep 2017 | - | $23.66M(-15.0%) |
| Jun 2017 | - | $27.84M(-11.6%) |
| Mar 2017 | - | $31.51M(+5.4%) |
| Dec 2016 | $139.70M(+3.5%) | $29.90M(-0.3%) |
| Sep 2016 | - | $29.99M(-7.3%) |
| Jun 2016 | - | $32.37M(-9.3%) |
| Mar 2016 | - | $35.70M(+4.6%) |
| Dec 2015 | $135.02M(+7.1%) | $34.13M(+5.4%) |
| Sep 2015 | - | $32.37M(-1.2%) |
| Jun 2015 | - | $32.75M(+5.7%) |
| Mar 2015 | - | $30.98M(-5.1%) |
| Dec 2014 | $126.02M(+51.4%) | $32.65M(+6.8%) |
| Sep 2014 | - | $30.59M(+8.1%) |
| Jun 2014 | - | $28.30M(-8.9%) |
| Mar 2014 | - | $31.07M(+41.4%) |
| Dec 2013 | $83.22M(+42.2%) | $21.97M(-6.6%) |
| Sep 2013 | - | $23.52M(+26.0%) |
| Jun 2013 | - | $18.66M(+8.3%) |
| Mar 2013 | - | $17.23M(+5.1%) |
| Dec 2012 | $58.50M(+34.4%) | $16.39M(+12.2%) |
| Sep 2012 | - | $14.60M(+9.5%) |
| Jun 2012 | - | $13.33M(+475.4%) |
| Mar 2012 | - | $2.32M(-1.2%) |
| Dec 2011 | $43.55M(+5.8%) | $2.34M(-79.6%) |
| Sep 2011 | - | $11.48M(+16.2%) |
| Jun 2011 | - | $9.88M(+2.3%) |
| Mar 2011 | - | $9.66M(+371.1%) |
| Dec 2010 | $41.17M(-6.9%) | $2.05M(+11.3%) |
| Sep 2010 | - | $1.84M(-2.6%) |
| Jun 2010 | - | $1.89M(-1.9%) |
| Mar 2010 | - | $1.93M(-85.4%) |
| Dec 2009 | $44.24M(+17.2%) | $13.19M(+84.3%) |
| Sep 2009 | - | $7.16M(-18.0%) |
| Jun 2009 | - | $8.72M(+21.5%) |
| Mar 2009 | - | $7.18M(-6.0%) |
| Dec 2008 | $37.74M(+123.2%) | $7.64M(-10.9%) |
| Sep 2008 | - | $8.58M(-17.2%) |
| Jun 2008 | - | $10.36M(+44.6%) |
| Mar 2008 | - | $7.17M(-47.5%) |
| Dec 2007 | $16.91M(-14.1%) | $13.66M(+227.0%) |
| Sep 2007 | - | $4.18M(+47.1%) |
| Jun 2007 | - | $2.84M(-32.4%) |
| Mar 2007 | - | $4.20M(-40.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $19.69M(-10.3%) | $7.02M(+14.2%) |
| Sep 2006 | - | $6.14M(-2.8%) |
| Jun 2006 | - | $6.32M(+119.6%) |
| Mar 2006 | - | $2.88M(-32.7%) |
| Dec 2005 | $21.95M(+7.4%) | $4.28M(-8.3%) |
| Sep 2005 | - | $4.66M(-4.9%) |
| Jun 2005 | - | $4.90M(-2.3%) |
| Mar 2005 | - | $5.02M(+31.8%) |
| Dec 2004 | $20.44M(+24.9%) | $3.81M(-0.3%) |
| Sep 2004 | - | $3.82M(-4.4%) |
| Jun 2004 | - | $3.99M(+103.4%) |
| Mar 2004 | - | $1.96M(-32.0%) |
| Dec 2003 | $16.37M(-22.4%) | $2.89M(+33.2%) |
| Sep 2003 | - | $2.17M(-32.2%) |
| Jun 2003 | - | $3.20M(-8.3%) |
| Mar 2003 | - | $3.48M(-3.0%) |
| Dec 2002 | $21.10M(-24.3%) | $3.59M(-21.1%) |
| Sep 2002 | - | $4.55M(-18.0%) |
| Jun 2002 | - | $5.55M(+3.5%) |
| Mar 2002 | - | $5.37M(-28.0%) |
| Dec 2001 | $27.87M(+65.0%) | $7.45M(+10.3%) |
| Sep 2001 | - | $6.76M(+5.5%) |
| Jun 2001 | - | $6.41M(+28.3%) |
| Mar 2001 | - | $4.99M(-64.7%) |
| Dec 2000 | $16.89M(+19.5%) | $14.14M(+226.9%) |
| Sep 2000 | - | $4.33M(+44.8%) |
| Jun 2000 | - | $2.99M(+2.9%) |
| Mar 2000 | - | $2.90M(+8.8%) |
| Dec 1999 | $14.14M(+34.7%) | - |
| Sep 1999 | - | $2.67M(+7.4%) |
| Jun 1999 | - | $2.48M(-15.3%) |
| Mar 1999 | - | $2.93M(-93.8%) |
| Dec 1998 | $10.50M(+14.1%) | - |
| Sep 1998 | - | $47.07M(+2498.8%) |
| Jun 1998 | - | $1.81M(+2.0%) |
| Mar 1998 | - | $1.78M(-15.4%) |
| Dec 1997 | $9.20M(-29.2%) | $2.10M(-8.7%) |
| Sep 1997 | - | $2.30M(-14.8%) |
| Jun 1997 | - | $2.70M(+22.7%) |
| Mar 1997 | - | $2.20M(-29.0%) |
| Dec 1996 | $13.00M(-11.0%) | $3.10M(+19.2%) |
| Sep 1996 | - | $2.60M(-44.7%) |
| Jun 1996 | - | $4.70M(+80.8%) |
| Mar 1996 | - | $2.60M(-33.3%) |
| Dec 1995 | $14.60M(-4.6%) | $3.90M(+5.4%) |
| Sep 1995 | - | $3.70M(+8.8%) |
| Jun 1995 | - | $3.40M(-5.6%) |
| Mar 1995 | - | $3.60M(+24.1%) |
| Dec 1994 | $15.30M(-9.5%) | $2.90M(-21.6%) |
| Sep 1994 | - | $3.70M(-15.9%) |
| Jun 1994 | - | $4.40M(+2.3%) |
| Mar 1994 | - | $4.30M(+2.4%) |
| Dec 1993 | $16.90M(+57.9%) | $4.20M(-10.6%) |
| Sep 1993 | - | $4.70M(+9.3%) |
| Jun 1993 | - | $4.30M(+4.9%) |
| Mar 1993 | - | $4.10M(-2.4%) |
| Dec 1992 | $10.70M(-25.2%) | - |
| Oct 1992 | - | $4.20M(+20.0%) |
| Jul 1992 | - | $3.50M(-14.6%) |
| Apr 1992 | - | $4.10M(+13.9%) |
| Apr 1992 | $14.30M(+5.9%) | - |
| Jan 1992 | - | $3.60M(+2.9%) |
| Oct 1991 | - | $3.50M(+12.9%) |
| Jul 1991 | - | $3.10M(-8.8%) |
| Apr 1991 | $13.50M(+12.5%) | $3.40M(+3.0%) |
| Jan 1991 | - | $3.30M(-2.9%) |
| Oct 1990 | - | $3.40M(0.0%) |
| Jul 1990 | - | $3.40M(+9.7%) |
| Apr 1990 | $12.00M(+39.5%) | $3.10M(-8.8%) |
| Jan 1990 | - | $3.40M |
| Apr 1989 | $8.60M(+36.5%) | - |
| Apr 1988 | $6.30M(+61.5%) | - |
| Apr 1987 | $3.90M(+95.0%) | - |
| Apr 1986 | $2.00M | - |
FAQ
- What is Celldex Therapeutics, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Celldex Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of CLDX is $202.10M
What is the all time high annual operating expenses for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual total operating expenses is $202.10M
What is Celldex Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, CLDX annual total operating expenses has changed by +$53.17M (+35.70%)
What is Celldex Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of CLDX is $63.71M
What is the all time high quarterly operating expenses for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly total operating expenses is $63.71M
What is Celldex Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, CLDX quarterly total operating expenses has changed by +$15.70M (+32.69%)